rdf:type |
|
lifeskim:mentions |
umls-concept:C0001925,
umls-concept:C0005516,
umls-concept:C0011854,
umls-concept:C0014257,
umls-concept:C0021368,
umls-concept:C0030705,
umls-concept:C0205250,
umls-concept:C0277785,
umls-concept:C0332307,
umls-concept:C0441889,
umls-concept:C0442805,
umls-concept:C1954261
|
pubmed:issue |
2
|
pubmed:dateCreated |
2009-1-27
|
pubmed:abstractText |
The inflammation marker YKL-40 is elevated in patients with type 2 diabetes and is associated with atherosclerosis and increased cardiovascular mortality. In the present study, YKL-40 levels were examined in patients with type 1 diabetes with increasing levels of albuminuria, known to be associated with an increased risk of cardiovascular disease.
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-10388530,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-10391393,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-10446083,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-11466120,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-11877368,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-11950696,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-12663607,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-12774166,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-15692810,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-16033329,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-16164620,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-16612564,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-16955240,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-17087877,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-17627189,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-17686944,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-18157633,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-18332153,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-18480670,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-2668076,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-3086326,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-7768902,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-8259139,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18957531-8432214
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1935-5548
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
323-8
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:18957531-Adipokines,
pubmed-meshheading:18957531-Adult,
pubmed-meshheading:18957531-Aged,
pubmed-meshheading:18957531-Albuminuria,
pubmed-meshheading:18957531-Biological Markers,
pubmed-meshheading:18957531-Blood Pressure,
pubmed-meshheading:18957531-Diabetes Mellitus, Type 1,
pubmed-meshheading:18957531-Diabetic Angiopathies,
pubmed-meshheading:18957531-Diabetic Nephropathies,
pubmed-meshheading:18957531-Female,
pubmed-meshheading:18957531-Glycoproteins,
pubmed-meshheading:18957531-Humans,
pubmed-meshheading:18957531-Inflammation,
pubmed-meshheading:18957531-Lectins,
pubmed-meshheading:18957531-Male,
pubmed-meshheading:18957531-Middle Aged,
pubmed-meshheading:18957531-Reference Values
|
pubmed:year |
2009
|
pubmed:articleTitle |
YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria.
|
pubmed:affiliation |
Department of Endocrinology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark. cnr@dadlnet.dk
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|